Access this stock data via API
Subscribe
CanSino Biologics Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 910.1M 377.1M 1.0B 4.3B
Cost of revenue 269.7M 1.3B 1.2B 1.3B
Gross profit 640.4M -957.1M -186.6M 3.0B
Operating expense
Research & development 459.1M 697.1M 778.3M 878.7M
Selling general and admin 621.6M 707.8M 544.7M 337.6M
Other operating expenses 1.9M 46.3M
Operating income -376.9M -2.3B -1.4B 1.8B
Non operating interest income
Income 70.5M 109.3M 65.9M 79.7M
Expense 66.2M 70.1M 41.3M 20.4M
Other income expense
Pretax income -420.6M -2.2B -1.2B 1.9B
Tax provision 2.7M -12.5M -219.2M 29.7M
Net income -423.3M -2.1B -964.8M 1.9B
Basic EPS -1.5 -6.0 -3.7 7.7
Diluted EPS -1.5 -6.0 -3.7 7.7
Basic average shares 272.4M 269.6M 228.2M 228.6M
Diluted average shares 272.4M 269.6M 228.2M 228.6M
EBITDA -75.3M -1.8B -1.0B 2.0B
Net income from continuing op. -420.6M -2.2B -1.2B 1.9B
Minority interests 4.8M 484.7M 55.3M 7.3M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 46 minutes

06:13
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).